Skip to main content
logo
Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
35.05
-0.05 (-0.14%)
At close: Dec 5, 2025, 4:00 PM EST
34.37
-0.68 (-1.94%)
After-hours: Dec 5, 2025, 5:03 PM EST

Revenue by Geography

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222017 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2017 - 2021
United States Revenue
-
Log In
Log In
Log In
Upgrade
Africa Revenue
-
Log In
Log In
Log In
Upgrade
China Revenue
-
Log In
Log In
Log In
Upgrade
United Kingdom Revenue
-
Log In
Log In
Log In
Upgrade
Rest of Europe Revenue
-
Log In
Log In
Log In
Upgrade
Asia Pacific/ Other Revenue
-
Log In
Log In
Log In
Upgrade
Revenue (Total)
593.82M
Log In
Log In
Log In
Upgrade

Revenue Breakdown

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222017 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2017 - 2021
Sample Management Solutions Revenue
325.00M
Log In
Log In
Log In
Upgrade
Multiomics Revenue
269.00M
Log In
Log In
Log In
Upgrade
B Medical Revenue
-
Log In
Log In
Log In
Upgrade
Revenue (Other)
-179.00K
Log In
Log In
Log In
Upgrade
Revenue (Total)
593.82M
Log In
Log In
Log In
Upgrade

Revenue Breakdown 2

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222017 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2017 - 2021
Revenue (Total)
593.82M
Log In
Log In
Log In
Upgrade

Revenue Breakdown 3

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222017 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2017 - 2021
Multiomics Revenue
269.00M
Log In
Log In
Log In
Upgrade
Core Products Revenue
-
Log In
Log In
Log In
Upgrade
Sample Repository Solutions Revenue
-
Log In
Log In
Log In
Upgrade
B Medical Revenue
-
Log In
Log In
Log In
Upgrade
Revenue (Total)
593.82M
Log In
Log In
Log In
Upgrade

Adjusted EBIT

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222017 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2017 - 2021
Sample Management Solutions Adjusted Operating Income
27.55M
Log In
Log In
Log In
Upgrade
Multiomics Adjusted Operating Income
-11.94M
Log In
Log In
Log In
Upgrade
B Medical Systems Adjusted Operating Income
-
Log In
Log In
Log In
Upgrade
Operating Income (Total)
-26.84M
Log In
Log In
Log In
Upgrade

Adjusted EBIT 2

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222017 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2017 - 2021
Life Sciences Product Adjusted Operating Income
-
Log In
Log In
Log In
Upgrade
Life Sciences Services Adjusted Operating Income
-
Log In
Log In
Log In
Upgrade
Operating Income (Total)
-26.84M
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222017 - 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2017 - 2021
Organic Revenue Growth
3.00%
Log In
Log In
Log In
Upgrade
Updated Nov 21, 2025. Data Source: Fiscal.ai.